[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 160
Citations 0
Correction
February 2018

Error in Data in the Results Section

JAMA Dermatol. 2018;154(2):230. doi:10.1001/jamadermatol.2018.0104

In the article titled “Management of Morgellons Disease With Low-Dose Trifluoperazine,”1 an error occurred in the last paragraph of the Results section concerning the number of patients who achieved at least partial responses and baseline function with median dosages of the study treatment. The sentence now reads, “Among patients with median dosages of 2 mg/d, 10 (71%) achieved at least partial responses and 7 (50%) achieved baseline function…”. The article was corrected online.

References
1.
Yan  BY, Jorizzo  JL.  Management of Morgellons disease with low-dose trifluoperazine  [published online January 10, 2018].  JAMA Dermatol. doi:10.1001/jamadermatol.2017.5175Google Scholar
×